Project Manager – Discovery, BioVersys AG
Trained as a biochemist, Andrej spent a more than a decade as a microbiologist studying the action of antibiotics and the evolution of resistance that follows their use. He joined BioVersys in late 2019 to develop agents targeting Staphylococcus aureus infection by blocking virulence factor production.